Ponnusamy Shunmuga Sundaram, Muthu Giridhar, Anand Vijesh
Department of Cardiology, Velammal Medical College Hospital and Research Institute, Madurai, Tamil Nadu, India.
J Innov Card Rhythm Manag. 2020 Sep 15;11(9):4242-4245. doi: 10.19102/icrm.2020.1100902. eCollection 2020 Sep.
Catheter ablation is considered as the standard treatment for all patients with symptomatic drug-refractory tachyarrhythmia. The safety and efficacy of the procedure in the adult population is well-established. Due to the small size of the patient and difficulty in attaining venous access, infants are rarely subjected to radiofrequency ablation. Here, we report a case of drug-refractory AV nodal re-entrant tachycardia in a two-year-old child. Radiofrequency ablation was performed with a 5-Fr sized medium-curve ablation catheter deployed at the slow pathway region where a fractionated A-wave with slow-pathway potential was recorded. After ablation, no recurrence of SVT at the end of 12 months of follow-up was observed.
导管消融被认为是所有有症状的药物难治性快速性心律失常患者的标准治疗方法。该手术在成人中的安全性和有效性已得到充分证实。由于患儿体型小且难以获得静脉通路,婴儿很少接受射频消融。在此,我们报告一例两岁儿童药物难治性房室结折返性心动过速的病例。使用一根5F大小的中弯消融导管在记录到带有慢径电位的碎裂A波的慢径区域进行射频消融。消融后,随访12个月结束时未观察到室上性心动过速复发。